The firm noted the company had a positive FDA panel and the valuation is more attractive ahead of the July 15 Prescription Drug User Fee Act date.
The stock was up 9.88% to $7.23 at 10:38 a.m.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Donald Trump's victory may be a win for Wall Street traders; Colgate-Palmolive remains on slippery slope; and more from TheStreet and its various properties.
MannKind bulls -- the rainbow-hued unicorns of the investment world -- believe the company's marketing efforts will succeed. They're wrong.